MyFinsight
Home
Blog
About
Proceeds from medtronic
term loan
$20,000K
Proceeds from the royalty
purchase agreement
$15,000K
Proceeds from
at-the-market offering, net of...
$5,855K
Proceeds from exercise of
stock options
$34K
(-62.64%↓ Y/Y)
Net cash provided by
(used in) financing...
$40,273K
(5662.57%↑ Y/Y)
Canceled cashflow
$616K
Net decrease in cash
and cash...
-$14,218K
(-304.84%↓ Y/Y)
Canceled cashflow
$40,273K
Stock-based compensation
$5,356K
(-13.82%↓ Y/Y)
Non-cash interest
expense on liability...
$3,111K
Accrued interest
expense on liability...
$442K
Non-cash lease expense
$325K
(9.43%↑ Y/Y)
Depreciation and
amortization
$186K
(13.41%↑ Y/Y)
Amortization of deferred
financing fees
$129K
(40.22%↑ Y/Y)
Inventory
-$60K
(-645.45%↓ Y/Y)
Accounts receivable
-$44K
(-388.89%↓ Y/Y)
Prepaid expenses and
other assets
-$14K
(90.54%↑ Y/Y)
Sales of marketable
securities
$38,791K
(19.71%↑ Y/Y)
Sale of strategic
investments
$4,781K
Restricted stock units
withheld for tax
$616K
(-24.42%↓ Y/Y)
Net cash used in
operating activities
-$41,500K
(-29.11%↓ Y/Y)
Canceled cashflow
$9,667K
Net cash (used in)
provided by investing...
-$12,991K
(-144.25%↓ Y/Y)
Total
revenue-Product
$198K
Canceled cashflow
$43,572K
Net loss
-$44,446K
(-16.60%↓ Y/Y)
Canceled cashflow
$198K
Accounts payable,
accrued expenses and...
-$3,311K
(-472.86%↓ Y/Y)
Gain on sale of
strategic investments
$2,286K
Accretion and interest
related to marketable...
$476K
(195.65%↑ Y/Y)
Operating lease
liabilities - current and...
-$359K
(-34.46%↓ Y/Y)
Change in the fair value
of derivative...
$289K
Purchases of marketable
securities
$56,125K
(1834.01%↑ Y/Y)
Purchases of property and
equipment
$438K
(200.00%↑ Y/Y)
Personnel and consulting
costs
$17,611K
Development costs-Clinical
Development Costs
$8,534K
Development costs-Non
Clinical Development...
$7,429K
Stock-based compensation
$5,356K
(-13.82%↓ Y/Y)
Other segment
expenses
$2,882K
Interest expense
(income), net
-$2,589K
Depreciation and
amortization expense
$186K
Cost of product
revenues
$57K
Back
Back
Cash Flow
Orchestra BioMed Holdings, Inc. (OBIO)
Orchestra BioMed Holdings, Inc. (OBIO)
source: myfinsight.com